Log In
BCIQ
Print this Print this
 

Combivent Respimat, ipratropium bromide/albuterol

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionIpratropium bromide and albuterol propellant-free inhaler
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/30/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today